United States· US:51662-1550_e3cada58-aa1c-8792-e053-2a95a90a388f
XYLOCAINE-MPF WITH EPI
A other agents for local oral treatment product containing xylocaine-mpf with epi, registered in United States by HF Acquisition Co LLC, DBA HealthFirst. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Xylocaine-mpf with epi is registered in 2 of 19 countries.
Countries holding a registration under ATC A01AD (other agents for local oral treatment), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Xylocaine-mpf with epi · ATC A01AD
2 / 19 countries
- Polandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- XYLOCAINE-MPF WITH EPI
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Country
- United States (US)
- ATC code
- A01AD
- ATC class
- Other agents for local oral treatment
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc11516621550325 POUCH in 1 CASE (51662-1550-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1550-2) / 20 mL in 1 VIAL, SINGLE-DOSE
Regulatory notes
Same class
Other records under A01AD
Other agents for local oral treatment, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/781bffa6-f370-4ee9-b647-709bb083fbf9 GET /v1/drugs/781bffa6-f370-4ee9-b647-709bb083fbf9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "30Q7KI53AK",
"rxcui": "203180",
"inchikey": "YLXIPWWIOISBDD-NDAAPVSOSA-N",
"display_name": "EPINEPHRINE BITARTRATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL",
"productid": "51662-1550_e3cada58-aa1c-8792-e053-2a95a90a388f",
"productndc": "51662-1550",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "006488",
"products": [
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "2%",
"product_no": "002",
"approval_date": "Approved Prior to Jan 1, 1982"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "0.01MG/ML;2%",
"product_no": "003",
"approval_date": "Approved Prior to Jan 1, 1982"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "0.01MG/ML;1%",
"product_no": "004",
"approval_date": "Approved Prior to Jan 1, 1982"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "0.02MG/ML;2%",
"product_no": "005",
"approval_date": "Approved Prior to Jan 1, 1982"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "1%",
"product_no": "007",
"approval_date": "Approved Prior to Jan 1, 1982"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "0.5%",
"product_no": "008",
"approval_date": "Approved Prior to Jan 1, 1982"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "1.5%",
"product_no": "010",
"approval_date": "Approved Prior to Jan 1, 1982"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "0.005MG/ML;0.5%",
"product_no": "012",
"approval_date": "Approved Prior to Jan 1, 1982"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "0.005MG/ML;1.5%",
"product_no": "017",
"approval_date": "Approved Prior to Jan 1, 1982"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "0.005MG/ML;1%",
"product_no": "018",
"approval_date": "Nov 13, 1986"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "0.005MG/ML;2%",
"product_no": "019",
"approval_date": "Nov 13, 1986"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS",
"shortage_reason": "Epinephrine Injection",
"shortage_status": "current",
"proprietary_name": "XYLOCAINE-MPF WITH EPI",
"active_ingred_unit": "mg/mL; mg/mL",
"application_number": "NDA006488",
"marketing_category": "NDA",
"nonproprietary_name": "XYLOCAINE-MPF WITH EPI",
"start_marketing_date": "20210628",
"active_numerator_strength": ".005; 20"
}See everything about xylocaine-mpf with epi.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.